Home/ Supplements/ Electrolytes/ Octacosanol+

Octacosanol+

product on market Tablet or Pill DaVinci Laboratories Of Vermont Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 20% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Policosanol and bee pollen are studied for potential lipid-lowering and energy-boosting effects, though evidence remains limited. Calcium and phosphorus support bone mineralization, while aspartic acid plays a role in amino acid metabolism. Overall, clinical evidence for this specific combination is sparse.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Octacosanol+
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
20%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calcium
120 mg (12% DV)
135 mg (14% DV)
Within RDA (0.2× RDA) 13 studies (A:0, B:3)
Policosanol
16 mg
Bee Pollen
500 mg
Market median: 2000.0mg (63 products)

Other Ingredients

Cellulose Stearic Acid Vegetable Stearate Silica Pharmaceutical Glaze
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 tablet, 1 or 2 times daily, or as directed by your health care practitioner.

Warnings & Precautions

Warning: If you are pregnant or nursing, consult your health care practitioner before taking this product.

Keep out of reach of children.

Formulation Notes

This product is free of citrus, corn and yeast.

Triacontanol and Octacosanol are the main components of the policosanol complex.

A Policosanol Product with Bee Pollen

Additional Information

TRUTH We pledge total truth in labeling. Our family of products contain only the purest and most potent ingredients. Guaranteed.

Policosanol is the generic term used for a mixture of long chain fatty alcohols found in beeswax, jams, sugar cane and wheat germ oil.

Color of this product may vary due to color variations of the natural ingredients.

Store in a cool, dry place.

0200363.060 0111A

Metadata

Product Details

UPC / SKU0 26664 23636 4
DSLD Entry Date2013-09-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID23308
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.